Raymond James Financial Services Advisors, Inc. Galera Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $66.3 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023
BUY
$1.48 - $2.68 $34,743 - $62,913
23,475 New
23,475 $60,000
Q4 2021

Feb 08, 2022
SELL
$1.27 - $8.28 $10,096 - $65,826
-7,950 Reduced 26.27%
22,311 $102,000
Q2 2021

Aug 11, 2021
BUY
$6.08 - $10.44 $6,080 - $10,440
1,000 Added 3.42%
30,261 $297,000
Q1 2021

May 14, 2021
BUY
$8.35 - $12.39 $5,845 - $8,673
700 Added 2.45%
29,261 $258,000
Q2 2020

Jul 17, 2020
BUY
$7.14 - $14.41 $203,925 - $411,564
28,561 New
28,561 $204,000

Others Institutions Holding GRTX

# of Institutions
38
Shares Held
10.7M
Call Options Held
10.3K
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email